Savara SVRA
NASDAQ SVRA
$5.37 +0.00 (+0.00%)
As of: Sep 4, 2026 · 3:59 PM EDT

Savara (SVRA) Change in Accured Expenses (2010 - 2026)

Savara (SVRA) posted quarterly Change in Accured Expenses of -$4.6 million for Q1 2026, down 47.24% year-over-year from -$8.8 million in Q1 2025, and down 227.09% quarter-over-quarter from $3.6 million in Q4 2025.

Analysis

Savara (SVRA) Change in Accured Expenses (2010 - 2026) Analysis & Trends

Savara (SVRA) has reported Change in Accured Expenses for 17 consecutive years, with -$4.6 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Change in Accured Expenses fell 47.24% year-over-year to -$4.6 million; the TTM figure through Mar 2026 stood at $3.3 million (up 82.06% YoY), while the FY2025 annual figure was $4.8 million, up 14.4% from the prior year.
  • Change in Accured Expenses retreated to -$4.6 million in Q1 2026 per SVRA's latest filing, from $3.6 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $3.6 million in Q4 2025 and bottomed at -$4.6 million in Q1 2026.
  • Historically, Change in Accured Expenses has averaged $505529.4 across 5 years, with a median of $1.2 million in 2025.
  • Annual changes were most pronounced in 2023 — Change in Accured Expenses soared 6075.0% — and 2025, when it plunged 308.83%.
  • Savara's Change in Accured Expenses stood at $445000.0 in 2022, then soared by 230.34% to $1.5 million in 2023, then jumped by 53.74% to $2.3 million in 2024, then jumped by 61.37% to $3.6 million in 2025, then plunged by 227.09% to -$4.6 million in 2026.
  • Business Quant data shows SVRA's Change in Accured Expenses at -$4.6 million in Q1 2026, $3.6 million in Q4 2025, and $3.1 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 11.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 55.78 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 212.44 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 61.62 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 68.82 Mn
10 Savara 1.36 Bn 1.36 Bn - 1.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.48 Mn
Mar 31, 2026 -4.64 Mn
Dec 31, 2025 3.65 Mn
Sep 30, 2025 3.12 Mn
Jun 30, 2025 1.19 Mn
Mar 31, 2025 -3.15 Mn
Dec 31, 2024 2.26 Mn
Sep 30, 2024 1.38 Mn
Jun 30, 2024 1.34 Mn
Mar 31, 2024 -770,000.00
Dec 31, 2023 1.47 Mn
Sep 30, 2023 3.06 Mn
Jun 30, 2023 988,000.00
Mar 31, 2023 -976,000.00
Dec 31, 2022 445,000.00
Sep 30, 2022 1.70 Mn
Jun 30, 2022 16,000.00
Mar 31, 2022 -2.48 Mn
Dec 31, 2021 -278,000.00
Sep 30, 2021 928,000.00